What is the official website of West Pharmaceutical Services ?

The official website of West Pharmaceutical Services is https://www.westpharma.com.

What is West Pharmaceutical Services's cybersecurity risk score?

West Pharmaceutical Services has an AI-generated cybersecurity risk score of 792 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has West Pharmaceutical Services experienced?

According to Rankiteo, West Pharmaceutical Services currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has West Pharmaceutical Services been affected by any supply chain cyber incidents ?

According to Rankiteo, West Pharmaceutical Services has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does West Pharmaceutical Services have SOC 2 Type 1 certification ?

According to Rankiteo, West Pharmaceutical Services is not certified under SOC 2 Type 1.

Does West Pharmaceutical Services have SOC 2 Type 2 certification ?

According to Rankiteo, West Pharmaceutical Services does not hold a SOC 2 Type 2 certification.

Does West Pharmaceutical Services comply with GDPR ?

According to Rankiteo, West Pharmaceutical Services is not listed as GDPR compliant.

Does West Pharmaceutical Services have PCI DSS certification ?

According to Rankiteo, West Pharmaceutical Services does not currently maintain PCI DSS compliance.

Does West Pharmaceutical Services comply with HIPAA ?

According to Rankiteo, West Pharmaceutical Services is not compliant with HIPAA regulations.

Does West Pharmaceutical Services have ISO 27001 certification ?

According to Rankiteo,West Pharmaceutical Services is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does West Pharmaceutical Services operate in ?

West Pharmaceutical Services operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does West Pharmaceutical Services have ?

West Pharmaceutical Services employs approximately 6,227 people worldwide.

Does West Pharmaceutical Services own any subsidiaries ?

West Pharmaceutical Services presently has no subsidiaries across any sectors.

How many LinkedIn followers does West Pharmaceutical Services have ?

West Pharmaceutical Services's official LinkedIn profile has approximately 129,972 followers.

What is the NAICS classification code for West Pharmaceutical Services ?

West Pharmaceutical Services is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does West Pharmaceutical Services have a Crunchbase profile ?

No, West Pharmaceutical Services does not have a profile on Crunchbase.

Does West Pharmaceutical Services have a LinkedIn profile ?

Yes, West Pharmaceutical Services maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/west-pharmaceutical-services.

How many cybersecurity incidents has West Pharmaceutical Services experienced ?

As of August 4, 2026, Rankiteo reports that West Pharmaceutical Services has not experienced any cybersecurity incidents.

How many peer or competitor companies does West Pharmaceutical Services have ?

West Pharmaceutical Services has an estimated 5,720 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

WPS

Boost Score +25 with badge (5 left)

792

/1000

Fair

817

/1000

Good

West Pharmaceutical Services Vendor Cyber Rating & Cyber Score

westpharma.com

Add Your Compliance Badge

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering billions of components and devices each year. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index.

WPS A.I CyberSecurity Scoring

Scoring History

WPS

West Pharmaceutical Services CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

WPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for WPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for West Pharmaceutical Services in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for West Pharmaceutical Services in 2026.

Incident Types WPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for West Pharmaceutical Services in 2026.

Incident History - WPS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

West Pharmaceutical Services Subsidiaries

WPS

Pharmaceutical Manufacturing

Website: https://www.westpharma.com

Company Size: 5,001-10,000 employees

West Contract ManufacturingPlastics Manufacturing

Loading…

West Pharmaceutical Services Similar Companies

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Loading…

NEWS

West Pharmaceutical Services CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 11, 2026 01:40 PM

Winners And Losers Of Q4: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much).

Read Article

March 09, 2026 09:07 PM

West Pharma CEO Eric Green to retire after 11 years at the helm

West Pharmaceutical's chief executive Eric Green said on Monday he plans to retire once the company ‌finds his successor, ending an 11-year...

Read Article

March 09, 2026 08:30 PM

After doubling sales and 350% return, West Pharma chief plans exit

West Pharmaceutical Services (NYSE: WST) announced that Eric M. Green plans to retire as President, CEO and Chair once a successor is hired,...

Read Article

February 28, 2026 08:00 AM

Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price?

If you are wondering whether West Pharmaceutical Services at around US$254 per share is offering fair value or stretching expectations,...

Read Article

February 25, 2026 08:00 AM

Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Read Article

February 24, 2026 08:00 AM

Here is Why West Pharmaceutical Services, Inc. (WST) is Strongly Favored by Hedge Funds

West Pharmaceutical Services, Inc. (NYSE:WST) is one of the 10 best life sciences stocks to buy according to hedge funds.

Read Article

February 20, 2026 08:00 AM

West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be...

Read Article

February 20, 2026 08:00 AM

Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?

West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock's...

Read Article

February 19, 2026 08:00 AM

Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players

Key market opportunities include smart technologies like NFC labels, advances in biologics requiring specialized packaging, and innovations...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-67978

SUMMARY

An issue in the SBN UDP interface of NASA cFS v7.0.1 allows attackers to cause a Denial of Service (DoS) via transmitting a crafted SBN frame.

Published

Date2026-08-03

Updated

Date2026-08-03

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/nasa/cFS/issues/1058

CVE-2026-67673

SUMMARY

A stack-based buffer overflow vulnerability exists in the cmd_edl function of OreSat Firmware v1.0. The vulnerability is triggered when processing the edl fw_flash command, where the <filename> argument is copied to a 64-byte stack buffer via memcpy without proper length validation. An attacker with physical access to the UART3 serial interface can exploit this vulnerability by sending a maliciously crafted command with an oversized filename parameter,

Published

Date2026-08-03

Updated

Date2026-08-03

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://github.com/dazuo233/cve/issues/2

CVE-2026-48399

SUMMARY

Adobe Campaign Classic (ACC) is affected by a Violation of Secure Design Principles vulnerability that could result in a Security feature bypass. An attacker could leverage this vulnerability to bypass security measures and gain unauthorized read access. Exploitation of this issue does not require user interaction.

Published

Date2026-08-03

Updated

Date2026-08-03

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://helpx.adobe.com/security/products/campaign/apsb26-120.html

CVE-2026-48333

SUMMARY

Adobe Campaign Classic (ACC) is affected by an Incorrect Authorization vulnerability that could result in privilege escalation. An attacker could exploit this vulnerability to gain elevated privileges. Exploitation of this issue does not require user interaction.

Published

Date2026-08-03

Updated

Date2026-08-03

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

https://helpx.adobe.com/security/products/campaign/apsb26-120.html

CVE-2026-48331

SUMMARY

Adobe Campaign Classic (ACC) is affected by a Server-Side Request Forgery (SSRF) vulnerability that could result in privilege escalation. Exploitation of this issue does not require user interaction. Scope is changed.

Published

Date2026-08-03

Updated

Date2026-08-03

RISK INFORMATION (Score: 10)

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://helpx.adobe.com/security/products/campaign/apsb26-120.html

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…